Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive examination. Proponents often stress the possibility for substantial therapeutic benefits, especially in conditions where conventional treatments have proven limited. However, this is to assess the substantial financial burden associated with CPI stem cell the